1 | inventory | 3,073 |
2 | checklist | 1,504 |
3 | angeles | 285 |
4 | inventory-ii | 86 |
5 | end-products | 82 |
6 | proneness | 52 |
7 | inventory-short | 49 |
8 | therapy-fatigue | 40 |
9 | endproducts | 34 |
10 | inventory-revised | 26 |
11 | checklist-90 | 23 |
12 | checklist-90-revised | 20 |
13 | inventory-2 | 19 |
14 | check-list | 13 |
15 | kads | 13 |
16 | scale-15 | 13 |
17 | cll4 | 11 |
18 | index-cancer | 11 |
19 | /fio2 | 10 |
20 | checklist-25 | 10 |
21 | checklist-community | 10 |
22 | in-tube | 10 |
23 | inventory-6 | 10 |
24 | scale-short | 10 |
25 | undersogelser | 10 |
26 | vulvae | 9 |
27 | checklist-90-r | 8 |
28 | disorder-7 | 8 |
29 | flex-tip | 8 |
30 | index-emesis | 8 |
31 | inventory-18 | 8 |
32 | inventory-second | 8 |
33 | q-sort | 8 |
34 | undersøgelser | 8 |
35 | 3-5d | 7 |
36 | checklist-20 | 7 |
37 | checklist-civilian | 7 |
38 | checklist-irritability | 7 |
39 | dotml | 7 |
40 | forschungsgemeinschaft | 7 |
41 | index-short | 7 |
42 | scale-11 | 7 |
43 | carepath | 6 |
44 | checklist-revised | 6 |
45 | disorder-not | 6 |
46 | emg-mmg | 6 |
47 | neuromyopathy | 6 |
48 | profile-child | 6 |
49 | scale-20 | 6 |
50 | scale-modified | 6 |
51 | syndrome/me | 6 |
52 | amigos | 5 |
53 | brabant | 5 |
54 | inventory-state | 5 |
55 | scale-depression | 5 |
56 | survey-21 | 5 |
57 | 10-scale | 4 |
58 | 180-load | 4 |
59 | checklist-military | 4 |
60 | pmcc | 4 |
61 | scale-interview | 4 |
62 | alamos | 3 |
63 | cryo/cuff | 3 |
64 | emg-f | 3 |
65 | inventory- | 3 |
66 | inventory-3 | 3 |
67 | inventory-4 | 3 |
68 | kragujevac | 3 |
69 | p5.0 | 3 |
70 | p7.2 | 3 |
71 | phosphodegron | 3 |
72 | pmhome | 3 |
73 | quechuas | 3 |
74 | reyes | 3 |
75 | scale-defined | 3 |
76 | test-geriatric | 3 |
77 | /auc0-t | 2 |
78 | 1-f | 2 |
79 | 160-169 | 2 |
80 | 1998b | 2 |
81 | 5-30/hour | 2 |
82 | aluco | 2 |
83 | ca-630 | 2 |
84 | cabos | 2 |
85 | durée | 2 |
86 | es/δt | 2 |
87 | gas-sterilized | 2 |
88 | gene-7 | 2 |
89 | guérin | 2 |
90 | halin | 2 |
91 | im/lvc | 2 |
92 | index-10 | 2 |
93 | indicé-48 | 2 |
94 | interview-japanese | 2 |
95 | inventory-taiwan | 2 |
96 | inventory-trait | 2 |
97 | inventory-youth | 2 |
98 | muddiness | 2 |
99 | myco | 2 |
100 | osteochondromatous | 2 |
101 | questionnaire-modified | 2 |
102 | ratones | 2 |
103 | reduct | 2 |
104 | scale-geriatrics | 2 |
105 | scale-preschool | 2 |
106 | scale-retrospective | 2 |
107 | scale-second | 2 |
108 | scale-survey | 2 |
109 | scale-teacher | 2 |
110 | scales-ii | 2 |
111 | scales-short | 2 |
112 | score-6 | 2 |
113 | scowl | 2 |
114 | syndrome-predominant | 2 |
115 | system-short | 2 |
116 | telangiectasia-mutated | 2 |
117 | whoqol-hivbref | 2 |
118 | α-2,3-sialyltransferase | 2 |
119 | ≥1.10 | 2 |
120 | -29.5mg/dl | 1 |
121 | -41.6mg/dl | 1 |
122 | -j68 | 1 |
123 | 0-2c | 1 |
124 | 0.9/0.9 | 1 |
125 | 1.8/2.1 | 1 |
126 | 10.8/h | 1 |
127 | 10.9+/-15.6 | 1 |
128 | 10113 | 1 |
129 | 10150 | 1 |
130 | 103·5 | 1 |
131 | 133-154 | 1 |
132 | 14.8+/-5.2 | 1 |
133 | 1744·9 | 1 |
134 | 2-phenyl-2,3-dihydrofuran | 1 |
135 | 209·6 | 1 |
136 | 22/546 | 1 |
137 | 24+/-82 | 1 |
138 | 3.7/h | 1 |
139 | 30+/-105 | 1 |
140 | 30.0+/-10.0 | 1 |
141 | 34/36o | 1 |
142 | 39.9±22 | 1 |
143 | 51.4±24.4/h | 1 |
144 | 58/21 | 1 |
145 | 74/296 | 1 |
146 | 8-oxabicyclo | 1 |
147 | 9,10-dihydro-9,10-dioxoanthracene-2,3,6,7-tetra-carboxyl-ate | 1 |
148 | =62.344 | 1 |
149 | =7.062 | 1 |
150 | _5.7 | 1 |
151 | alimentos | 1 |
152 | angeles–based | 1 |
153 | anthracene-2,3,6,7-tetra-carboxyl-ate | 1 |
154 | atment | 1 |
155 | aupetit | 1 |
156 | battery-dementia | 1 |
157 | bionix | 1 |
158 | bpvi | 1 |
159 | checklist-13 | 1 |
160 | checklist-14 | 1 |
161 | checklist-90- | 1 |
162 | checklist-90r | 1 |
163 | checklist-community-measured | 1 |
164 | checklist-ii | 1 |
165 | checklist-monitor | 1 |
166 | checklist-screening | 1 |
167 | checklist-specific | 1 |
168 | checklist/1.5-5 | 1 |
169 | checklist/2-3 | 1 |
170 | cheecklist-90 | 1 |
171 | classroom-wide | 1 |
172 | climacium | 1 |
173 | depression» | 1 |
174 | disorder/major | 1 |
175 | disorders-2nd | 1 |
176 | duration=20years | 1 |
177 | endoproducts | 1 |
178 | endproduct/receptor | 1 |
179 | end‑products | 1 |
180 | especially.numerous | 1 |
181 | evaluation-profile | 1 |
182 | events/d | 1 |
183 | factors-positive | 1 |
184 | frisbee | 1 |
185 | gem05menos65 | 1 |
186 | gonpo | 1 |
187 | greyii | 1 |
188 | hydra1.1 | 1 |
189 | i-ie | 1 |
190 | idal | 1 |
191 | ii/pcrf | 1 |
192 | iii-iv=0.86 | 1 |
193 | iiia/iiib/iv | 1 |
194 | im/n-im | 1 |
195 | immediately/6 | 1 |
196 | improvement=1.28 | 1 |
197 | in-dp/dt | 1 |
198 | index-15 | 1 |
199 | index-15-item | 1 |
200 | index-18 | 1 |
201 | index-aaos/modems | 1 |
202 | index/international | 1 |
203 | index/short | 1 |
204 | instrument-2nd | 1 |
205 | intenvory-ii | 1 |
206 | inventary | 1 |
207 | inventory-21 | 1 |
208 | inventory-2nd | 1 |
209 | inventory-anxiety | 1 |
210 | inventory-apathy | 1 |
211 | inventory-bd | 1 |
212 | inventory-bdi-ii | 1 |
213 | inventory-brain | 1 |
214 | inventory-dutch | 1 |
215 | inventory-ii/bdi-ii | 1 |
216 | inventory-q | 1 |
217 | inventorythe | 1 |
218 | inventroy | 1 |
219 | invertory | 1 |
220 | knowledge/efficacy | 1 |
221 | koch-institut | 1 |
222 | kp-45 | 1 |
223 | ld/fx | 1 |
224 | leaves-stems | 1 |
225 | libres | 1 |
226 | ligorio | 1 |
227 | line/maintenance/subsequent | 1 |
228 | list-short | 1 |
229 | m5fcells | 1 |
230 | markers- | 1 |
231 | mashonensebeverley-burton | 1 |
232 | micro-shunt | 1 |
233 | monitoring/management | 1 |
234 | morio | 1 |
235 | nierenzentren | 1 |
236 | obsessive-compulsive-scale | 1 |
237 | ofischemia | 1 |
238 | ofpiritramide | 1 |
239 | oppenness | 1 |
240 | pas-add | 1 |
241 | pertainings | 1 |
242 | polycyanoanions | 1 |
243 | post-icbt | 1 |
244 | pre-plec | 1 |
245 | primeros | 1 |
246 | proview | 1 |
247 | pyridyl-nitrones | 1 |
248 | questionnaire-hospital | 1 |
249 | questionnaire-rpq | 1 |
250 | questionnaires-3® | 1 |
251 | rating-single | 1 |
252 | ratings/classroom | 1 |
253 | reduction.• | 1 |
254 | ref/2011/05/002346 | 1 |
255 | response/latent | 1 |
256 | rs3769818 | 1 |
257 | scale-14 | 1 |
258 | scale-30 | 1 |
259 | scale-3a | 1 |
260 | scale-adult | 1 |
261 | scale-condensed | 1 |
262 | scale-group | 1 |
263 | scale-patient | 1 |
264 | scale-seasonal | 1 |
265 | scale-thai | 1 |
266 | scale-trait | 1 |
267 | scale-vietnam | 1 |
268 | scale.we | 1 |
269 | scale/diagnostic | 1 |
270 | scale/ham-d | 1 |
271 | sceening | 1 |
272 | score-qol | 1 |
273 | score-tss | 1 |
274 | score=8 | 1 |
275 | screening/education | 1 |
276 | sensitivity-fear | 1 |
277 | sensitivity-specific | 1 |
278 | severity-particularly | 1 |
279 | site-visit | 1 |
280 | soft/loose | 1 |
281 | stari | 1 |
282 | survey-long | 1 |
283 | survey-v15 | 1 |
284 | syndrome.establishment | 1 |
285 | t1/post-contrast | 1 |
286 | tetrakisphosphate | 1 |
287 | thatsairei-to | 1 |
288 | tianepine | 1 |
289 | tight-rope | 1 |
290 | toldos | 1 |
291 | types-hyperosmolar | 1 |
292 | uplc-esi | 1 |
293 | visco-analyser | 1 |
294 | w.s.d. | 1 |
295 | were.observed | 1 |
296 | xiii-xiv | 1 |
297 | β=-0.339 | 1 |
298 | β=-0.373 | 1 |
299 | ≤1.30 | 1 |
300 | ≤178° | 1 |
301 | ≥164mmhg | 1 |
302 | ⩽10/h | 1 |
1 | -29.5mg/dl | 1 |
2 | -41.6mg/dl | 1 |
3 | -j68 | 1 |
4 | /auc0-t | 2 |
5 | /fio2 | 10 |
6 | 0-2c | 1 |
7 | 0.9/0.9 | 1 |
8 | 1-f | 2 |
9 | 1.8/2.1 | 1 |
10 | 10-scale | 4 |
11 | 10.8/h | 1 |
12 | 10.9+/-15.6 | 1 |
13 | 10113 | 1 |
14 | 10150 | 1 |
15 | 103·5 | 1 |
16 | 133-154 | 1 |
17 | 14.8+/-5.2 | 1 |
18 | 160-169 | 2 |
19 | 1744·9 | 1 |
20 | 180-load | 4 |
21 | 1998b | 2 |
22 | 2-phenyl-2,3-dihydrofuran | 1 |
23 | 209·6 | 1 |
24 | 22/546 | 1 |
25 | 24+/-82 | 1 |
26 | 3-5d | 7 |
27 | 3.7/h | 1 |
28 | 30+/-105 | 1 |
29 | 30.0+/-10.0 | 1 |
30 | 34/36o | 1 |
31 | 39.9±22 | 1 |
32 | 5-30/hour | 2 |
33 | 51.4±24.4/h | 1 |
34 | 58/21 | 1 |
35 | 74/296 | 1 |
36 | 8-oxabicyclo | 1 |
37 | 9,10-dihydro-9,10-dioxoanthracene-2,3,6,7-tetra-carboxyl-ate | 1 |
38 | =62.344 | 1 |
39 | =7.062 | 1 |
40 | _5.7 | 1 |
41 | alamos | 3 |
42 | alimentos | 1 |
43 | aluco | 2 |
44 | amigos | 5 |
45 | angeles | 285 |
46 | angeles–based | 1 |
47 | anthracene-2,3,6,7-tetra-carboxyl-ate | 1 |
48 | atment | 1 |
49 | aupetit | 1 |
50 | battery-dementia | 1 |
51 | bionix | 1 |
52 | bpvi | 1 |
53 | brabant | 5 |
54 | ca-630 | 2 |
55 | cabos | 2 |
56 | carepath | 6 |
57 | check-list | 13 |
58 | checklist | 1,504 |
59 | checklist-13 | 1 |
60 | checklist-14 | 1 |
61 | checklist-20 | 7 |
62 | checklist-25 | 10 |
63 | checklist-90 | 23 |
64 | checklist-90- | 1 |
65 | checklist-90-r | 8 |
66 | checklist-90-revised | 20 |
67 | checklist-90r | 1 |
68 | checklist-civilian | 7 |
69 | checklist-community | 10 |
70 | checklist-community-measured | 1 |
71 | checklist-ii | 1 |
72 | checklist-irritability | 7 |
73 | checklist-military | 4 |
74 | checklist-monitor | 1 |
75 | checklist-revised | 6 |
76 | checklist-screening | 1 |
77 | checklist-specific | 1 |
78 | checklist/1.5-5 | 1 |
79 | checklist/2-3 | 1 |
80 | cheecklist-90 | 1 |
81 | classroom-wide | 1 |
82 | climacium | 1 |
83 | cll4 | 11 |
84 | cryo/cuff | 3 |
85 | depression» | 1 |
86 | disorder-7 | 8 |
87 | disorder-not | 6 |
88 | disorder/major | 1 |
89 | disorders-2nd | 1 |
90 | dotml | 7 |
91 | duration=20years | 1 |
92 | durée | 2 |
93 | emg-f | 3 |
94 | emg-mmg | 6 |
95 | end-products | 82 |
96 | endoproducts | 1 |
97 | endproduct/receptor | 1 |
98 | endproducts | 34 |
99 | end‑products | 1 |
100 | es/δt | 2 |
101 | especially.numerous | 1 |
102 | evaluation-profile | 1 |
103 | events/d | 1 |
104 | factors-positive | 1 |
105 | flex-tip | 8 |
106 | forschungsgemeinschaft | 7 |
107 | frisbee | 1 |
108 | gas-sterilized | 2 |
109 | gem05menos65 | 1 |
110 | gene-7 | 2 |
111 | gonpo | 1 |
112 | greyii | 1 |
113 | guérin | 2 |
114 | halin | 2 |
115 | hydra1.1 | 1 |
116 | i-ie | 1 |
117 | idal | 1 |
118 | ii/pcrf | 1 |
119 | iii-iv=0.86 | 1 |
120 | iiia/iiib/iv | 1 |
121 | im/lvc | 2 |
122 | im/n-im | 1 |
123 | immediately/6 | 1 |
124 | improvement=1.28 | 1 |
125 | in-dp/dt | 1 |
126 | in-tube | 10 |
127 | index-10 | 2 |
128 | index-15 | 1 |
129 | index-15-item | 1 |
130 | index-18 | 1 |
131 | index-aaos/modems | 1 |
132 | index-cancer | 11 |
133 | index-emesis | 8 |
134 | index-short | 7 |
135 | index/international | 1 |
136 | index/short | 1 |
137 | indicé-48 | 2 |
138 | instrument-2nd | 1 |
139 | intenvory-ii | 1 |
140 | interview-japanese | 2 |
141 | inventary | 1 |
142 | inventory | 3,073 |
143 | inventory- | 3 |
144 | inventory-18 | 8 |
145 | inventory-2 | 19 |
146 | inventory-21 | 1 |
147 | inventory-2nd | 1 |
148 | inventory-3 | 3 |
149 | inventory-4 | 3 |
150 | inventory-6 | 10 |
151 | inventory-anxiety | 1 |
152 | inventory-apathy | 1 |
153 | inventory-bd | 1 |
154 | inventory-bdi-ii | 1 |
155 | inventory-brain | 1 |
156 | inventory-dutch | 1 |
157 | inventory-ii | 86 |
158 | inventory-ii/bdi-ii | 1 |
159 | inventory-q | 1 |
160 | inventory-revised | 26 |
161 | inventory-second | 8 |
162 | inventory-short | 49 |
163 | inventory-state | 5 |
164 | inventory-taiwan | 2 |
165 | inventory-trait | 2 |
166 | inventory-youth | 2 |
167 | inventorythe | 1 |
168 | inventroy | 1 |
169 | invertory | 1 |
170 | kads | 13 |
171 | knowledge/efficacy | 1 |
172 | koch-institut | 1 |
173 | kp-45 | 1 |
174 | kragujevac | 3 |
175 | ld/fx | 1 |
176 | leaves-stems | 1 |
177 | libres | 1 |
178 | ligorio | 1 |
179 | line/maintenance/subsequent | 1 |
180 | list-short | 1 |
181 | m5fcells | 1 |
182 | markers- | 1 |
183 | mashonensebeverley-burton | 1 |
184 | micro-shunt | 1 |
185 | monitoring/management | 1 |
186 | morio | 1 |
187 | muddiness | 2 |
188 | myco | 2 |
189 | neuromyopathy | 6 |
190 | nierenzentren | 1 |
191 | obsessive-compulsive-scale | 1 |
192 | ofischemia | 1 |
193 | ofpiritramide | 1 |
194 | oppenness | 1 |
195 | osteochondromatous | 2 |
196 | p5.0 | 3 |
197 | p7.2 | 3 |
198 | pas-add | 1 |
199 | pertainings | 1 |
200 | phosphodegron | 3 |
201 | pmcc | 4 |
202 | pmhome | 3 |
203 | polycyanoanions | 1 |
204 | post-icbt | 1 |
205 | pre-plec | 1 |
206 | primeros | 1 |
207 | profile-child | 6 |
208 | proneness | 52 |
209 | proview | 1 |
210 | pyridyl-nitrones | 1 |
211 | q-sort | 8 |
212 | quechuas | 3 |
213 | questionnaire-hospital | 1 |
214 | questionnaire-modified | 2 |
215 | questionnaire-rpq | 1 |
216 | questionnaires-3® | 1 |
217 | rating-single | 1 |
218 | ratings/classroom | 1 |
219 | ratones | 2 |
220 | reduct | 2 |
221 | reduction.• | 1 |
222 | ref/2011/05/002346 | 1 |
223 | response/latent | 1 |
224 | reyes | 3 |
225 | rs3769818 | 1 |
226 | scale-11 | 7 |
227 | scale-14 | 1 |
228 | scale-15 | 13 |
229 | scale-20 | 6 |
230 | scale-30 | 1 |
231 | scale-3a | 1 |
232 | scale-adult | 1 |
233 | scale-condensed | 1 |
234 | scale-defined | 3 |
235 | scale-depression | 5 |
236 | scale-geriatrics | 2 |
237 | scale-group | 1 |
238 | scale-interview | 4 |
239 | scale-modified | 6 |
240 | scale-patient | 1 |
241 | scale-preschool | 2 |
242 | scale-retrospective | 2 |
243 | scale-seasonal | 1 |
244 | scale-second | 2 |
245 | scale-short | 10 |
246 | scale-survey | 2 |
247 | scale-teacher | 2 |
248 | scale-thai | 1 |
249 | scale-trait | 1 |
250 | scale-vietnam | 1 |
251 | scale.we | 1 |
252 | scale/diagnostic | 1 |
253 | scale/ham-d | 1 |
254 | scales-ii | 2 |
255 | scales-short | 2 |
256 | sceening | 1 |
257 | score-6 | 2 |
258 | score-qol | 1 |
259 | score-tss | 1 |
260 | score=8 | 1 |
261 | scowl | 2 |
262 | screening/education | 1 |
263 | sensitivity-fear | 1 |
264 | sensitivity-specific | 1 |
265 | severity-particularly | 1 |
266 | site-visit | 1 |
267 | soft/loose | 1 |
268 | stari | 1 |
269 | survey-21 | 5 |
270 | survey-long | 1 |
271 | survey-v15 | 1 |
272 | syndrome-predominant | 2 |
273 | syndrome.establishment | 1 |
274 | syndrome/me | 6 |
275 | system-short | 2 |
276 | t1/post-contrast | 1 |
277 | telangiectasia-mutated | 2 |
278 | test-geriatric | 3 |
279 | tetrakisphosphate | 1 |
280 | thatsairei-to | 1 |
281 | therapy-fatigue | 40 |
282 | tianepine | 1 |
283 | tight-rope | 1 |
284 | toldos | 1 |
285 | types-hyperosmolar | 1 |
286 | undersogelser | 10 |
287 | undersøgelser | 8 |
288 | uplc-esi | 1 |
289 | visco-analyser | 1 |
290 | vulvae | 9 |
291 | w.s.d. | 1 |
292 | were.observed | 1 |
293 | whoqol-hivbref | 2 |
294 | xiii-xiv | 1 |
295 | α-2,3-sialyltransferase | 2 |
296 | β=-0.339 | 1 |
297 | β=-0.373 | 1 |
298 | ≤1.30 | 1 |
299 | ≤178° | 1 |
300 | ≥1.10 | 2 |
301 | ≥164mmhg | 1 |
302 | ⩽10/h | 1 |
1 | checklist-90- | 1 |
2 | markers- | 1 |
3 | inventory- | 3 |
4 | w.s.d. | 1 |
5 | 30.0+/-10.0 | 1 |
6 | p5.0 | 3 |
7 | index-10 | 2 |
8 | ≥1.10 | 2 |
9 | scale-20 | 6 |
10 | checklist-20 | 7 |
11 | scale-30 | 1 |
12 | ≤1.30 | 1 |
13 | ca-630 | 2 |
14 | 10150 | 1 |
15 | cheecklist-90 | 1 |
16 | checklist-90 | 23 |
17 | hydra1.1 | 1 |
18 | 1.8/2.1 | 1 |
19 | scale-11 | 7 |
20 | survey-21 | 5 |
21 | inventory-21 | 1 |
22 | 58/21 | 1 |
23 | inventory-2 | 19 |
24 | 14.8+/-5.2 | 1 |
25 | p7.2 | 3 |
26 | 39.9±22 | 1 |
27 | =7.062 | 1 |
28 | 24+/-82 | 1 |
29 | /fio2 | 10 |
30 | checklist/2-3 | 1 |
31 | inventory-3 | 3 |
32 | checklist-13 | 1 |
33 | 10113 | 1 |
34 | β=-0.373 | 1 |
35 | inventory-4 | 3 |
36 | scale-14 | 1 |
37 | checklist-14 | 1 |
38 | =62.344 | 1 |
39 | 133-154 | 1 |
40 | cll4 | 11 |
41 | checklist/1.5-5 | 1 |
42 | 30+/-105 | 1 |
43 | scale-15 | 13 |
44 | index-15 | 1 |
45 | survey-v15 | 1 |
46 | checklist-25 | 10 |
47 | kp-45 | 1 |
48 | gem05menos65 | 1 |
49 | 103·5 | 1 |
50 | score-6 | 2 |
51 | inventory-6 | 10 |
52 | 10.9+/-15.6 | 1 |
53 | immediately/6 | 1 |
54 | ref/2011/05/002346 | 1 |
55 | 22/546 | 1 |
56 | iii-iv=0.86 | 1 |
57 | 74/296 | 1 |
58 | 209·6 | 1 |
59 | gene-7 | 2 |
60 | disorder-7 | 8 |
61 | _5.7 | 1 |
62 | index-18 | 1 |
63 | inventory-18 | 8 |
64 | rs3769818 | 1 |
65 | improvement=1.28 | 1 |
66 | indicé-48 | 2 |
67 | -j68 | 1 |
68 | score=8 | 1 |
69 | 0.9/0.9 | 1 |
70 | β=-0.339 | 1 |
71 | 160-169 | 2 |
72 | 1744·9 | 1 |
73 | scale-3a | 1 |
74 | ofischemia | 1 |
75 | battery-dementia | 1 |
76 | 1998b | 2 |
77 | 0-2c | 1 |
78 | kragujevac | 3 |
79 | pmcc | 4 |
80 | pre-plec | 1 |
81 | checklist-specific | 1 |
82 | sensitivity-specific | 1 |
83 | test-geriatric | 3 |
84 | scale/diagnostic | 1 |
85 | im/lvc | 2 |
86 | scale/ham-d | 1 |
87 | events/d | 1 |
88 | 3-5d | 7 |
89 | 180-load | 4 |
90 | inventory-bd | 1 |
91 | pas-add | 1 |
92 | scale-modified | 6 |
93 | questionnaire-modified | 2 |
94 | scale-defined | 3 |
95 | checklist-community-measured | 1 |
96 | angeles–based | 1 |
97 | checklist-90-revised | 20 |
98 | checklist-revised | 6 |
99 | inventory-revised | 26 |
100 | scale-condensed | 1 |
101 | telangiectasia-mutated | 2 |
102 | were.observed | 1 |
103 | gas-sterilized | 2 |
104 | profile-child | 6 |
105 | disorders-2nd | 1 |
106 | instrument-2nd | 1 |
107 | inventory-2nd | 1 |
108 | scale-second | 2 |
109 | inventory-second | 8 |
110 | vulvae | 9 |
111 | in-tube | 10 |
112 | ofpiritramide | 1 |
113 | classroom-wide | 1 |
114 | frisbee | 1 |
115 | inventorythe | 1 |
116 | i-ie | 1 |
117 | 10-scale | 4 |
118 | obsessive-compulsive-scale | 1 |
119 | rating-single | 1 |
120 | evaluation-profile | 1 |
121 | syndrome/me | 6 |
122 | pmhome | 3 |
123 | tianepine | 1 |
124 | tight-rope | 1 |
125 | α-2,3-sialyltransferase | 2 |
126 | interview-japanese | 2 |
127 | soft/loose | 1 |
128 | anthracene-2,3,6,7-tetra-carboxyl-ate | 1 |
129 | 9,10-dihydro-9,10-dioxoanthracene-2,3,6,7-tetra-carboxyl-ate | 1 |
130 | tetrakisphosphate | 1 |
131 | inventory-state | 5 |
132 | therapy-fatigue | 40 |
133 | scale-retrospective | 2 |
134 | factors-positive | 1 |
135 | scale.we | 1 |
136 | durée | 2 |
137 | 1-f | 2 |
138 | emg-f | 3 |
139 | whoqol-hivbref | 2 |
140 | cryo/cuff | 3 |
141 | ii/pcrf | 1 |
142 | ≥164mmhg | 1 |
143 | emg-mmg | 6 |
144 | sceening | 1 |
145 | checklist-screening | 1 |
146 | survey-long | 1 |
147 | ⩽10/h | 1 |
148 | 51.4±24.4/h | 1 |
149 | 3.7/h | 1 |
150 | 10.8/h | 1 |
151 | inventory-dutch | 1 |
152 | carepath | 6 |
153 | inventory-youth | 2 |
154 | scale-thai | 1 |
155 | inventory-bdi-ii | 1 |
156 | inventory-ii/bdi-ii | 1 |
157 | scales-ii | 2 |
158 | checklist-ii | 1 |
159 | inventory-ii | 86 |
160 | intenvory-ii | 1 |
161 | greyii | 1 |
162 | stari | 1 |
163 | uplc-esi | 1 |
164 | bpvi | 1 |
165 | idal | 1 |
166 | index/international | 1 |
167 | scale-seasonal | 1 |
168 | questionnaire-hospital | 1 |
169 | -29.5mg/dl | 1 |
170 | -41.6mg/dl | 1 |
171 | dotml | 7 |
172 | scale-preschool | 2 |
173 | score-qol | 1 |
174 | scowl | 2 |
175 | scale-vietnam | 1 |
176 | index-15-item | 1 |
177 | im/n-im | 1 |
178 | ratings/classroom | 1 |
179 | climacium | 1 |
180 | checklist-civilian | 7 |
181 | 2-phenyl-2,3-dihydrofuran | 1 |
182 | inventory-taiwan | 2 |
183 | nierenzentren | 1 |
184 | inventory-brain | 1 |
185 | halin | 2 |
186 | guérin | 2 |
187 | scale-depression | 5 |
188 | screening/education | 1 |
189 | phosphodegron | 3 |
190 | mashonensebeverley-burton | 1 |
191 | 34/36o | 1 |
192 | aluco | 2 |
193 | myco | 2 |
194 | ligorio | 1 |
195 | morio | 1 |
196 | 8-oxabicyclo | 1 |
197 | gonpo | 1 |
198 | thatsairei-to | 1 |
199 | flex-tip | 8 |
200 | scale-group | 1 |
201 | inventory-q | 1 |
202 | questionnaire-rpq | 1 |
203 | checklist-90-r | 8 |
204 | checklist-90r | 1 |
205 | sensitivity-fear | 1 |
206 | types-hyperosmolar | 1 |
207 | index-cancer | 11 |
208 | scale-teacher | 2 |
209 | undersogelser | 10 |
210 | undersøgelser | 8 |
211 | visco-analyser | 1 |
212 | disorder/major | 1 |
213 | checklist-monitor | 1 |
214 | endproduct/receptor | 1 |
215 | 5-30/hour | 2 |
216 | quechuas | 3 |
217 | scale-geriatrics | 2 |
218 | kads | 13 |
219 | angeles | 285 |
220 | pyridyl-nitrones | 1 |
221 | ratones | 2 |
222 | libres | 1 |
223 | reyes | 3 |
224 | pertainings | 1 |
225 | index-emesis | 8 |
226 | m5fcells | 1 |
227 | index-aaos/modems | 1 |
228 | leaves-stems | 1 |
229 | polycyanoanions | 1 |
230 | cabos | 2 |
231 | toldos | 1 |
232 | amigos | 5 |
233 | alamos | 3 |
234 | primeros | 1 |
235 | alimentos | 1 |
236 | duration=20years | 1 |
237 | proneness | 52 |
238 | muddiness | 2 |
239 | oppenness | 1 |
240 | score-tss | 1 |
241 | end-products | 82 |
242 | endproducts | 34 |
243 | endoproducts | 1 |
244 | end‑products | 1 |
245 | especially.numerous | 1 |
246 | osteochondromatous | 2 |
247 | /auc0-t | 2 |
248 | post-icbt | 1 |
249 | reduct | 2 |
250 | in-dp/dt | 1 |
251 | forschungsgemeinschaft | 7 |
252 | scale-trait | 1 |
253 | inventory-trait | 2 |
254 | site-visit | 1 |
255 | aupetit | 1 |
256 | scale-adult | 1 |
257 | brabant | 5 |
258 | syndrome-predominant | 2 |
259 | scale-patient | 1 |
260 | monitoring/management | 1 |
261 | syndrome.establishment | 1 |
262 | atment | 1 |
263 | response/latent | 1 |
264 | line/maintenance/subsequent | 1 |
265 | micro-shunt | 1 |
266 | disorder-not | 6 |
267 | scale-short | 10 |
268 | system-short | 2 |
269 | scales-short | 2 |
270 | list-short | 1 |
271 | index-short | 7 |
272 | inventory-short | 49 |
273 | index/short | 1 |
274 | q-sort | 8 |
275 | t1/post-contrast | 1 |
276 | check-list | 13 |
277 | checklist | 1,504 |
278 | koch-institut | 1 |
279 | es/δt | 2 |
280 | iiia/iiib/iv | 1 |
281 | xiii-xiv | 1 |
282 | proview | 1 |
283 | scale-interview | 4 |
284 | ld/fx | 1 |
285 | bionix | 1 |
286 | knowledge/efficacy | 1 |
287 | scale-survey | 2 |
288 | inventory-apathy | 1 |
289 | neuromyopathy | 6 |
290 | severity-particularly | 1 |
291 | inventroy | 1 |
292 | checklist-military | 4 |
293 | inventary | 1 |
294 | inventory | 3,073 |
295 | invertory | 1 |
296 | inventory-anxiety | 1 |
297 | checklist-irritability | 7 |
298 | checklist-community | 10 |
299 | reduction.• | 1 |
300 | questionnaires-3® | 1 |
301 | ≤178° | 1 |
302 | depression» | 1 |